Core Messages
Malassezia yeasts have been implicated in the pathogenesis of a variety of different human diseases. These include the common skin infection, pityriasis versicolor (PV), along with systemic infection, particularly in neonates. Increasingly, though, they are associated with other conditions where the roleof Malassezia in the pathogenesis is less clear and, in some cases, speculative. Examples include the common skin diseases, psoriasis and seborrhoeic dermatitis, as well as much rarer conditions, such as confluent and reticulate papillomatosis.
PV is a superficial infection associated mainly with M. globosa. It is a non-life threatening condition that presents with scaling. Diagnosis depends on the demonstration of organisms by direct microscopy, and treatment is usually successfully accomplished either by topical or systemic imidazole therapy. Associated diseases include folliculitis, which is an infection associated with symptomatic hair follicle invasion by Malassezia, responding to antifungal therapy along with conditions, such as psoriasis and cephalic pustulosis where the connection between the organisms and the disease is less clearly established. In the case of onychomycosis, there is little evidence that Malassezia yeasts are implicated in nail plate invasion, although this may be a rare occurrence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acosta Quintero ME, Cazorla Perfetti DJ (2004) Clinical-epidemiological aspects of pityriasis versicolor (PV) in a fishing community of the semiarid region in Falcon State, Venezuela. Rev Iberoam Micol 21:191-194
Ponnighaus JM, Fine PE, Saul J (1996) The epidemiology of pityriasis versicolor in Malawi, Africa. Mycoses 39:467-470
Ferié J, Dinkela A, Mbata M et al (2006) Skin disorders among school children in rural Tanzania and an assessment of therapeutic needs. Trop Doct 36:219-221
Jena DK, Sengupta S, Dwari BC et al (2005) Pityriasis versicolor in the pediatric age group. Indian J Dermatol Venereol Leprol 71:259-261
Johnson ML, Johnson KG, Engel A (1984) Prevalence, morbidity and cost of dermatologic diseases. J Am Acad Dermatol 11:930-936
Aspiroz C, Ara M, Varea M et al (2002) Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia 154:111-117
Hellgren L, Vincent J (1983) The incidence of tinea versicolor in central Sweden. J Med Microbiol 16:501-502
Ingordo V, Naldi L, Colecchia B et al (2003) Prevalence of pityriasis versicolor in young Italian sailors. Br J Dermatol 149:1270-1272
Cermeño JR, Hernandez I, Godoy G et al (2005) Mycoses at Hospital Universitario “Ruiz y Paez”, Ciudad Bolivar, Venezuela 2002. Invest Clin 46:37-42
Ellabib MS, Khalifa Z, Kavanagh K (2002) Dermatophytes and other fungi associated with skin mycoses in Tripoli Libya. Mycoses 45:101
Hafez M, el Shamy S (1985) Genetic susceptibility in pityriasis versicolor. Dermatol 171:86-88
He SM, Du WD, Yang S et al (2008) The genetic epidemiology of tinea versicolor in China. Mycoses 51:55-62
Borelli D, Jacobs PH, Nall L (1991) Tinea versicolor: epidemiologic, clinical and therapeutic aspects. J Am Acad Dermatol 25:300-305
Burke RC (1961) Tinea versicolor: susceptibility factors and experimental infection in human beings. J Invest Dermatol 36:389-401
Gupta AK, Batra R, Bluhm R et al (2004) Skin diseases associated with Malassezia species. J Am Acad Dermatol 51:785-798
Gülec AT, Demirbilek M, Seckin D et al (2003) Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol 49:187-192
Roberts SOB (1969) Pityrosporum orbiculare: incidence and distribution on clinically normal skin. Br J Dermatol 81:264-269
Rivers JK, Norris PG, Murphy GM et al (1989) UVA sunbeds: tanning, photoprotection, acute adverse effects and immunological changes. Br J Dermatol 120:767-777
Crespo-Erchiga V, Delgado Florencio V (2002) Malassezia species in skin diseases. Curr Opin Infect Dis 15:133-142
Patel SD, Noble WC (1993) Analyses of skin surface lipid in patients with microbially associated skin disease. Clin Exp Dermatol 18:405-409
Nazzaro Porro M, Passi S, Picardo M (1986) Lipoxygenase activity of Pityrosporum in vitro and in vivo. J Invest Dermatol 87:108-112
De Luca C, Picardo M, Breathnach A et al (1996) Lipoperoxidase activity of Pityrosporum: characterisation of by-products and possible role in pityriasis versicolor. Exp Dermatol 5:49-56
Thoma W, Kramer HJ, Mayser P (2005) Pityriasis versicolor alba. J Eur Acad Dermatol Venereol 19:147-152
Gordon MA (1951) Lipophilic yeast organism associated with tinea versicolor. J Invest Dermatol 17:267-272
Crespo-Erchiga V, Ojeda A, Vera A et al (1999) Aislamiento e identificacion de Malassezia spp en pitiriasis versicolor, dermatitis seborreica y piel sana. Rev Iberoam Micol 16:S16-21
Crespo-Erchiga V, Ojeda A, Vera A et al (1999) Mycology of pityriasis versicolor. J Mycol Méd 9:143-148
Crespo-Erchiga V, Ojeda A, Vera A et al (2000) Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 143:799-803
Nakabayashi A, Sei Y, Guillot J (2000) Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 38:337-341
Gupta AK, Kohli Y, Faergemann J et al (2001) Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol 39:199-206
Hernandez F, Mendez LJ, Bazan E et al (2003) Especies de Malassezia asociadas a diversas dermatosis y a piel sana en población mexicana. Rev Iberoam Micol 20:141-144
Dutta S, Bajaj AK, Basu S et al (2002) Pityriasis versicolor: socio-economic and clinico-mycologic study in India. Int J Dermatol 41:823-824
Tarazooie B, Kordbacheh P, Zaini F et al (2004) Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran. BMC Dermatol 4:5-8
Makni F, Ben Salah I, Affes M et al (2004) Identification des espèces de Malassezia isolées des lésions de pityriasis versicolor et des sujets sains dans la région de Sfax (Tunisie). Abst FSMM J Mycol Méd 14:159
Ben Salah S, Affes M, Makni F et al (2005) Les levures du genre Malassezia: identification moléculaire par nested-PCR des souches isolées à partir des différentes affections dermiques. Abst FSMM. J Mycol Méd 15:175
Gaitanis G, Velegraki A, Alexopoulos EC et al (2006) Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the mayor pityriasis versicolor isolate M. globosa. Br J Dermatol 154:854-859
Prohic A, Ozagovic L (2007) Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor. Mycoses 50:58-63
Crespo-Erchiga V, Delgado Florencio V (2006) Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 19:139-147
Nakabayashi A (2002) Identification of Malassezia associated dermatoses. Jap J Med Mycol 43:65-68
Gaitanis G, Velegraki A, Frangoulis E et al (2002) Identification of Malassezia species from patient skin scales by PCR-RFLP. Clin Microbiol Infect 8:162-173
Razanakolona I, Rakotozandrindrainy N, Razafimahefa J et al (2004) Pityriasis versicolor à Antananarivo: première étude sur l´identification d´espèces de Malassezia responsables. Abst FSMM J Mycol Méd 14:152
De Quinzada M (2005) Estudio de las especies de Malassezia relacionadas con la patología cutánea pitiriasis versicolor en Panamá. Thesis Doctoral, Panamá
Miranda KC, Rodrigues de Araujo C, Soares AJ et al (2006) Identificaçâo de espécies de Malassezia em pacientes com pitiríase versicolor em Goiania-GO. Rev Soc Bras Med Trop 39:582-583
Panja G (1928) The Malassezia of the skin, their cultivation, morphology and species. Trans 7th Congress Far East Assoc Trop Med 2:442-453
Castellani A (1935) Pityriasis versicolor tropicalis. Proc R Soc Med 28:1558
Midgley G (2000) The lipophilic yeasts: state of the art and prospects. Med Mycol 38(suppl 1):9-16
Roberts SOB (1969) Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol 81:315-326
Borelli D (1985) Pityriasis versicolor due to Malassezia ovalis. Mycopathol 89:147-153
Crowson AN, Magro CM (2003) Atrophying tinea versicolor: a clinical and histological study of 12 patients. Intern J Dermatol 42:928-932
Savin R (1996) Diagnosis and treatment of tinea versicolor. J Family Pract 43:127-132
Schwartz RA (2004) Superficial fungal infections. Lancet 364:1173-1182
Crespo-Erchiga V, Guého E (2005) Superficial diseases caused by Malassezia species. In: Merz WG, Hay RJ (eds) Medical mycology. Topley and Wilson’s microbiology and microbial infections, 10th edn. Arnold, London, pp 202-216
Guého E, Midgley G, Guillot J (1996) The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 69:337-355
Gupta AK, Kogan N, Batra R (2005) Pityriasis versicolor: a review of pharmacological treatment options. Expert Opin Pharmacother 6:165-178
Faergemann J, Fredriksson T (1980) Propylene glycol in the treatment of pityriasis versicolor. Acta Derm Venereol (Stockh) 60:92-93
Katsambas A, Rigopoulos D, Antoniou C et al (1996) Econazole 1% shampoo versus selenium in the treatment of tinea versicolor: a single-blind randomized clinical study. Int J Dermatol 35:667-668
Mellen LA, Vallee J, Feldman SR et al (2004) Treatment of pityriasis versicolor in the United States. J Dermatol Treatment 15:189-192
Svejgaard E (1973) Double blind trial of miconazole in dermatomycosis. Acta Derm Venereol (Stockh) 53:497-499
Tanenbaum L, Anderson C, Rosenberg MJ et al (1984) 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study. Arch Dermatol 120:216-219
Sugita T, Tajima M, Ito T et al (2005) Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 43:2824-2829
Hay RJ, Midgley G (1984) Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol 9:571-573
Jacobs PH (1985) Evolution in the treatment of pityriasis versicolor. In: Meinhof W (ed) Oral therapy in dermatomycoses: a step forward. Medical Publishing Foundation, Oxford, pp 107-110
Delescluse J (1990) Itraconazole in tinea versicolor: a review. J Am Acad Dermatol 23:551-554
Galimberti RL, Villalba I, Galarza S et al (1987) Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment. Rev Infect Dis 9(suppl 1):S134-S138
Kose O, Bülent Tastan H, Riza Gur A et al (2002) Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor. J Dermatol Treat 13:73-76
Partap R, Kaur I, Chakrabarti A et al (2004) Single-dose fluconazole versus itraconazole in pityriasis versicolor. Dermatology 208:55-59
Farschian M, Yaghoobi R, Samadi K (2002) Fluconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat 13:73-76
Garau M, Pereiro M Jr, del Palacio A (2003) In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob Agents Chemother 47:2342-2344
Velegraki A, Alexopoulos EC, Kritikou S et al (2004) Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J Clin Microbiol 42:3589-3593
Faergemann J, Ausma J, Vandeplassche L et al (2007) The efficacy of oral treatment with pramiconazole in pityriasis versicolor: a phase II a trial. Br J Dermatol 156:1385-1388
Levy A, Feuilhade de Chauvin M, Dubertret L et al (2007) Folliculites à Malassezia. Caractéristiques et réponses thérapeutiques chez 26 malades. Ann Dermatol Vénéréol 134:823-828
Crespo A, Crespo V, Sanz A (1990) Folliculitis por Malassezia. Dos casos tratados con ketoconazol. Rev Iberoam Micol 7:119-121
Alves EV, Martins JE, Ribeiro EB et al (2000) Pityrosporum folliculitis: renal transplantation case report. J Dermatol 27:49-51
Garau M, Relaño MT, Molina L et al (2003) Foliculitis en paciente con enfermedad de Hodgkin. Enferm Infec Microbiol Clin 21:101-102
Archer-Dubon C, Icaza-Chivez ME, Orozco-Topete R et al (1999) An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection. Int J Dermatol 38:453-456
Rhie S, Turcios R, Buckley H et al (2000) Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant 19:215-219
Guého E, Faergemann J, Lyman C et al (1994) Malassezia and Trichosporon: two emerging pathogenic basidiomycetous yeast-like fungi. J Med Vet Mycol 32:367-378
Faergemann J (1999) Pityrosporum species as a cause of allergy and infection. Allergy 54:413-419
Bäck O, Fergemann J, Hornqvist R (1985) Pityrosporum folliculitis: a common disease of the young and middle aged. J Am Acad Dermatol 12:56-61
Faergemann J, Johansson S, Back O et al (1986) An inmunologic and cultural study of Pityrosporum folliculitis. J Am Acad Dermatol 14:429-433
Sina B, Kauffman CL, Samorodin CS (1995) Intrafollicular mucin deposits in Pityrosporum folliculitis. J Am Acad Dermatol 32:807-809
Roberts SOB, Lachapelle JM (1969) Confluent and reticulate papillomatosis (Gougerot-Carteaud) and Pityrosporum orbiculare. Br J dermatol 81:841-845
Nordby CA, Mitchell AJ (1986) Confluent and reticulated papillomatosis responsive to selenium sulfide. Int J Dermatol 25:194-199
Shimizu S, Han-Yaku H (1997) Confluent and reticulated papillomatosis responsive to Minocycline. Dermatol 194:59-61
Baalbaki SA, Malak JA, Al-Khars MA (1993) Confluent and reticulated papillomatosis: treatment with etretinate. Arch Dermatol 129:961-963
Raja Babu KK, Snehal S, Sudha Vani D (2000) Confluent and reticulate papillomatosis: successful treatment with azithromycin. Br J Dermatol 142:1252-1253
Gülec AT, Seçkin D (1999) Confluent and reticulate papillomatosis: treatment with topical calcipotriol. Br J Dermatol 141:1150-1151
Ginarte M, Fabeiro JM, Toribio J (2002) Confluent and reticulate papillomatosis (Gougerot-Carteaud) successfully treated with tacalcitol. J Dermatol Treatment 13:27-30
Stein JA, Shin HT, Chang MW (2005) Confluent and reticulated papillomatosis associated with tinea versicolor in three siblings. Ped Dermatol 22:331-333
Rapelanoro R, Mortureux P, Couprie B et al (1996) Neonatal Malassezia furfur pustulosis. Arch Dermatol 132:190-193
Niamba P, Weill FX, Sarlangue J et al (1998) Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis? Arch Dermatol 134:995-998
Aractingi S, Cdranel S, Reygagne P et al (1991) Pustulose néonatale induite par Malassezia furfur. Ann Dermatol Vénéréol 118:856-858
Pont V, Grau C, Del Pino M et al (1998) Pustulosis neonatal por Malassezia furfur. Actas Dermosifiliogr 89:199-205
Bernier V, Weill FX, Hirigoyen V et al (2002) Skin colonization by Malassezia species in neonates. A prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 138:215-218
Koseki S, Takahashi S (1988) Serial observation on the colonization of Pityrosporum orbiculare (ovale) on the facial skin surface of newborn infants. Jpn J Med Mycol 29: 209-215
Borderon JC, Langier J, Vaillant MC (1989) Colonisation du nouveu-né par Malassezia furfur. Bull Soc Fr Mycol Méd 1:129-132
Ayhan M, Sancak B, Karaduman A et al (2007) Colonization of neonate skin by Malassezia species: Relatioship with neonatal cephalic pustulosis. J Am Acad Dermatol 57:1012-1018
Chai FC, Auret K, Christiansen K et al (2000) Malignant otitis externa caused by Malassezia sympodialis. Head Neck 22:87-89
Guillot J, Bond R (1999) Malassezia pachydermatis: a review. Med Mycol 37:295-306
Crespo MJ, Abarca ML, Cabañes FJ (2000) Atypical lipid-dependent Malassezia species isolated from dogs with otitis externa. J Clin Microbiol 38:2383-2385
Crespo MJ, Abarca ML, Cabanes FJ (2000) Otitis externa associated with Malassezia sympodialis in two cats. J Clin Microbiol 38:1263-1266
Crozier WJ, Wise KA (1993) Onicomicosis due to Pityrosporum. Austral J Dermatol 34:109-112
Escobar ML, Carmona-Fonseca J, Santamaria L (1999) Onicomicosis por Malassezia. Rev Iberoam Micol 16:225-229
Silva V, Moreno GA, Zaror L et al (1997) Isolation of Malassezia furfur from patients with onicomicosis. J Med Vet Mycol 35:73-74
Lopes JO (1994) Nodular infection of the hair caused by Malassezia furfur. Mycopathologia 125:149-152
Ertam I, Aytimur D, Alper S (2007) Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient. Indian J Dermatol Venereol Leprol 73:425-426
Chowdary A, Randhawa HS, Sharma S et al (2005) Malassezia furfur in a case of onychomycosis: colonizer or etiologic agent. Med Mycol 43:87-90
Blumenthal H (1971) Tinea versicolor of the penis. Arch Dermatol 103:461-462
Nia AK, Smith EL (1979) Pityriasis versicolor of the glans penis. Br J Venereol Dis 55:230
Smith EL (1978) Pityriasis versicolor of the penis. Br J Vener Dis 54:441
Mayser P, Schütz H, Schuppe C et al (2001) Frequency and spectrum of Malassezia yeasts in the area of the prepuce and glans penis. BJU Int 8:554-558
Aridogan A, Ilkit M, Izol V et al (2005) Malassezia and Candida colonization on glans penis of circumcised men. Mycoses 48:352-356
Iskit S, Ilkit M, Turc-Bicer A et al (2006) Effect of circumcision on genital colonization of Malassezia spp. in a pediatric population. Med Mycol 44:113-117
Suzuki T, Hori N, Miyake T et al (2007) Keratitis caused by a rare fungus, Malassezia restricta. Jpn J Ophtalmol 51:292-294
Rivolta S (1873) In: Di Giulio Speirani F (ed) Parasiti vegetali, 1st edn. Torino, pp 469-470
Lober CW, Belew PW, Rosemberg EW et al (1982) Patch test with killed sonicated microflora in patients with psoriasis. Arch Dermatol 118:322-325
Rosenberg EW, Belew PW (1982) Improvement of psoriasis of the scalp with ketoconazole. Arch Dermatol 118:370-371
Farr PM, Krause LB, Marks JM et al (1985) Response of scalp psoriasis to oral ketoconazole. Lancet 26:921-922
Rosenberg EW, Noah PW, Skinner RB et al (1989) Microbial associations of 167 patientswith psoriasis. Acta Derm Venereol Suppl (Stockh) 146:72-74
Elewski B (1990) Does Pityrosporum ovale have a role in psoriasis? Arch Dermatol 126:1111-1112
Narang T, Dogra S, Kaur I et al (2007) Malassezia and psoriasis: Koebner´s phenomenon or direct causation? JEADV 21:1111-1112
Gupta AK, Kohli Y, Summerbell RC et al (2001) Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 39:243-251
Prohic A (2003) Identification of Malassezia species isolated from scalp skin of patients with psoriasis and healthy subjects. Acta Dermatol Venereol Croat 11:1-8
Takahata Y, Sugita T, Hiruma M et al (2007) Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real-time polymerase chain reaction assay. Br J Dermatol 157:670-673
Squiquera L, Galimberti R, Morelli L et al (1994) Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clin Exp Dermatol 19:289-293
Kanda N, Tani K, Enomoto U et al (2002) The skin fungus-induced Th-1 and Th-2 related cytokine, chemokine and psostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris. Clin Exp Allerg 32:1243-1250
Baroni A, Paoletti I, Ruocco E et al (2004) Possible role of Malassezia furfur in psoriasis: modulation of TGF-beta1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J Cut Pathol 31:35-42
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Erchiga, V.C., Hay, R.J. (2010). Pityriasis Versicolor and Other Malassezia Skin Diseases. In: Boekhout, T., Mayser, P., Guého-Kellermann, E., Velegraki, A. (eds) Malassezia and the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03616-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-03616-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03615-6
Online ISBN: 978-3-642-03616-3
eBook Packages: MedicineMedicine (R0)